BACKGROUND: Roux-en-Y gastric bypass (RYGBP) controls obesity and comorbidities. However, there is no consensus on ring placement due to its complications. Surgical ring removal has been the standard approach, despite its inherent morbidity risks. Endoscopic dilation with achalasia balloon is a novel and minimally invasive option. We aimed to evaluate safety and efficacy of aggressive dilation as an outpatient procedure to treat food intolerance after banded RYGBP without stenosis; we also analyzed long-term weight regain. METHODS: This prospective study included 63 patients presenting with more than four vomiting episodes per week. Therapeutic endoscopy with a 30-mm balloon (Rigiflex®) was performed with radioscopic guidance in the first 16 patients (25.4 %). Four dilation sessions were performed in 12 patients (19 %), three in 14 (22.2 %), two in 24 (38 %), and one in 13 (20.6 %). RESULTS: Complete symptom improvement was achieved in 59 patients (93.6 %), partial improvement in 2 (3.2 %), and failure in 2, leading to ring removal by laparotomy. Complications rate was 9.5 %, including three cases of bleeding, two intragastric ring erosions, and one pneumoperitoneum; all treated clinically with no need for reintervention. Mean preoperative body mass index (BMI) was 42.4 kg/m(2) and postoperative (before endoscopic treatment) BMI was 25.3 kg/m(2). At a mean follow-up of 46.1 months after endoscopic intervention, mean BMI was 27.8 kg/m(2). CONCLUSIONS: Aggressive endoscopic dilation for food intolerance is a safe and minimally invasive method that promotes symptom improvement. It avoided reoperation in 96.8 % of patients and led to a low rate of weight regain.
BACKGROUND: Roux-en-Y gastric bypass (RYGBP) controls obesity and comorbidities. However, there is no consensus on ring placement due to its complications. Surgical ring removal has been the standard approach, despite its inherent morbidity risks. Endoscopic dilation with achalasia balloon is a novel and minimally invasive option. We aimed to evaluate safety and efficacy of aggressive dilation as an outpatient procedure to treat food intolerance after banded RYGBP without stenosis; we also analyzed long-term weight regain. METHODS: This prospective study included 63 patients presenting with more than four vomiting episodes per week. Therapeutic endoscopy with a 30-mm balloon (Rigiflex®) was performed with radioscopic guidance in the first 16 patients (25.4 %). Four dilation sessions were performed in 12 patients (19 %), three in 14 (22.2 %), two in 24 (38 %), and one in 13 (20.6 %). RESULTS: Complete symptom improvement was achieved in 59 patients (93.6 %), partial improvement in 2 (3.2 %), and failure in 2, leading to ring removal by laparotomy. Complications rate was 9.5 %, including three cases of bleeding, two intragastric ring erosions, and one pneumoperitoneum; all treated clinically with no need for reintervention. Mean preoperative body mass index (BMI) was 42.4 kg/m(2) and postoperative (before endoscopic treatment) BMI was 25.3 kg/m(2). At a mean follow-up of 46.1 months after endoscopic intervention, mean BMI was 27.8 kg/m(2). CONCLUSIONS: Aggressive endoscopic dilation for food intolerance is a safe and minimally invasive method that promotes symptom improvement. It avoided reoperation in 96.8 % of patients and led to a low rate of weight regain.
Authors: Antonio Carlos Valezi; Jorge Mali Junior; Mariano Almeida de Menezes; Edivaldo Macedo de Brito; Shirley A F de Souza Journal: Obes Surg Date: 2010-11 Impact factor: 4.129
Authors: Ricardo Arceo-Olaiz; María Nayví España-Gómez; Jorge Montalvo-Hernández; David Velázquez-Fernández; Juan Pablo Pantoja; Miguel F Herrera Journal: Surg Obes Relat Dis Date: 2008-01-28 Impact factor: 4.734
Authors: Josemberg Marins Campos; Luis Fernando Evangelista; Alvaro Antônio B Ferraz; Manoel P Galvao Neto; Eduardo Guimarães H De Moura; Paulo Sakai; Edmundo M Ferraz Journal: Gastrointest Endosc Date: 2010-05-20 Impact factor: 9.427
Authors: Daniel Blero; Pierre Eisendrath; Alain Vandermeeren; Jean Closset; Abdel Mehdi; Olivier Le Moine; Jacques Devière Journal: Gastrointest Endosc Date: 2009-09-12 Impact factor: 9.427
Authors: Kamal K Mahawar; Chirag Parikh; William R J Carr; Neil Jennings; Shlok Balupuri; Peter K Small Journal: Obes Surg Date: 2014-10 Impact factor: 4.129
Authors: R Vilallonga; J L Pereira-Cunill; S Morales-Conde; I Alarcón; I Breton; E Domínguez-Adame; J V Ferrer; A Garcia Ruiz-de-Gordejuela; A Goday; A Lecube; E Martín García-Almenta; M Á Rubio; F J Tinahones; P P García-Luna Journal: Obes Surg Date: 2019-12 Impact factor: 4.129